Answers are grounded in this paper and cite their sources.
Administration of GA or DMF is associated with differences in gut microbial composition in patients with MS. Because those changes affect critical metabolic pathways, we hypothesize that our findings may highlight mechanisms of pathophysiology and potential therapeutic intervention requiring further investigation.
No takes yet. Share an insight, caveat, or question.
Sand et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: